This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABX-MA1

Amgen, Inc.

Drug Names(s):
ABX-MA1

Description:
ABX-MA1 is a XenoMouse-derived fully human monoclonal antibody that binds to MUC18. MUC18 is also expressed on the cell surfaces of sarcomas, including smooth muscle and blood vessel-derived sarcomas, prostate and renal cell cancers making these potential future indications.Relevant peer-reviewed, published preclinical literature demonstrates that MUC18 and related molecules are appropriate therapeutic targets for malignant melanoma.

Informa UK Limited is a company registered in England and Wales with company number 1072954 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Informa UK Limited is part of Informa PLC.